WWM
BIIB icon

Westwood Wealth Management’s Biogen BIIB Stock Holding History

Westwood Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,125
Closed -$291K – 40
2023
Q4 		$291K Sell
1,125
-50
-4% -$12.3K 0.22% 31
2023
Q3 		$302K Hold
1,175
– – 0.2% 37
2023
Q2 		$335K Hold
1,175
– – 0.24% 37
2023
Q1 		$327K Sell
1,175
-135
-10% -$37.4K 0.29% 38
2022
Q4 		$363K Buy
1,310
+135
+11% +$38.1K 0.44% 33
2022
Q3 		$314K Sell
1,175
-135
-10% -$28.7K 0.28% 38
2022
Q2 		$267K Sell
1,310
-1,530
-54% -$313K 0.31% 37
2022
Q1 		$598 Sell
2,840
-1,400
-33% -$304K 0.23% 38
2021
Q4 		$1.02M Buy
+4,240
New +$1.09M 0.43% 30

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Westwood Wealth Management's BIIB Position: Q1 2024 in Review

Westwood Wealth Management sold out of Biogen (BIIB) in Q1 2024, closing a stake of 1,125 shares — an estimated $291K sold.

Westwood Wealth Management first reported a position in BIIB in Q4 2021 and held it in 9 quarters. The position peaked at $1.02M in Q4 2021. 955 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.

  • Westwood Wealth Management reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
  • Westwood Wealth Management sold 1,125 Biogen shares in Q1 2024, an estimated $291K.
  • Westwood Wealth Management first reported a position in Biogen in Q4 2021 and held it in 9 quarters.
  • Westwood Wealth Management's Biogen position peaked at $1.02M in Q4 2021.
  • 955 funds tracked by Wall St. Rank held Biogen as of Q1 2024.

Based on Westwood Wealth Management's 13F filing for Q1 2024, filed 1 May 2024.